ANGIODYNAMICS INC — Director's Dealing 2020

Dec 21, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2020-12-18

Reporting Person: Helsel Dave (SVP Global Operations and R&D)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-18	Common Stock	F	733	$14.29	Disposed	22615	Direct

Footnotes

F1: The exempt disposition of 733 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on December 18, 2017.